v1
A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer.
Identifier:nobleid.org/w1/20260515/AFFA2ABE
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/AFFA2ABE)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims